---
title: "Bicycle Therapeutics (BCYC.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BCYC.US/norm.md"
symbol: "BCYC.US"
name: "Bicycle Therapeutics"
parent: "https://longbridge.com/en/quote/BCYC.US.md"
datetime: "2026-06-10T09:53:34.857Z"
locales:
  - [en](https://longbridge.com/en/quote/BCYC.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BCYC.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BCYC.US/norm.md)
---

# Bicycle Therapeutics (BCYC.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.8729 | -0.2906 | -0.8528 | -1.14 | -0.8780 |
| ROE | -41.79% | -13.12% | -36.73% | -44.82% | -31.70% |
| Revenue | 887000.00 | 47.95M | 11.73M | 2.92M | 9.98M |
| Net income | -60.83M | -20.15M | -59.10M | -78.95M | -60.75M |
| Operating income | -65.48M | -20.51M | -65.55M | -86.60M | -70.20M |
| Gross margin | -5193.80% | 4.25% | -382.46% | -2332.50% | -474.03% |
| Net margin | -6857.38% | -42.03% | -503.66% | -2703.84% | -608.94% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 652.40M | 717.60M | 763.95M | 832.18M | 883.89M |
| Leverage | 1.18 | 1.18 | 1.24 | 1.24 | 1.19 |
| BVPS | 7.95 | 8.79 | 8.92 | 9.66 | 10.70 |
| Turnover | 0.0827 | 0.0867 | 0.0322 | 0.0204 | 0.0359 |
| Cash & STI | 559.47M | 628.11M | 648.33M | 721.45M | 792.97M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 20.27M | 21.91M | 11.42M | 14.11M | 15.45M |
| Net debt | -544.14M | -611.26M | -642.58M | -714.25M | -784.65M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -65.92M | -19.35M | -71.17M | -72.79M | -86.37M |
| Investing CF | -713000.00 | -574000.00 | -674000.00 | -498000.00 | -604000.00 |
| Financing CF | -54000.00 | -15000.00 | -30000.00 | -45000.00 | -41000.00 |
| Free CF | -45.27M | 25.02M | -46.24M | -43.11M | -57.09M |
| OCF coverage | -8462.77% | -3110.29% | -10095.46% | -13379.78% | -13349.30% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -713000.00 | -574000.00 | -674000.00 | -498000.00 | -604000.00 |